How Are Human-Relevant Disease Models Accelerating Growth in the Organoids Market?
The global Organoids Market is expected to witness rapid growth as pharmaceutical companies, biotechnology firms, and research institutions increasingly adopt human-relevant three-dimensional (3D) organoid models to accelerate drug discovery, disease modeling, and regenerative medicine research. According to Future Market Insights (FMI), the market is projected to expand from USD 91.8 million...
0 Комментарии
0 Поделились
301 Просмотры